CircSAMD4A

ncRNA information

ncRNA name

CircSAMD4A

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-218-5p/KLF8

Cancer information

Cancer name

Osteosarcoma

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

CircSAMD4A contributes to cell doxorubicin resistance in osteosarcoma by regulating the miR-218-5p/KLF8 axis

Tissue resource

tumor tissues and para-carcinoma tissues from osteosarcoma patients

human osteosarcoma cell lines HOS

human osteosarcoma cell lines U2OS

human osteoblast cell line hFOB1.19

Experiment

None


Institute

Shaoxing Shangyu People's Hospital

Shanghai Academy of Life Science

Country

China

China

Continent

Asia

Asia